Stocks
Assembly Biosciences, Inc.ASMB
NASDAQHealthcareBiotechnology$28.11-0.65%
A clinical-stage biotechnology company developing antiviral therapeutics targeting serious viral diseases, including hepatitis B and recurrent herpesvirus infections. Its pipeline centers on small-molecule candidates designed to disrupt viral replication and persistence, with programs advancing thro...
Market Cap: $444.7M52W Range: $7.75 – $39.71
Congressional Interest in Assembly Biosciences, Inc. (ASMB)
1 member of Congress has disclosed 2 trades in Assembly Biosciences, Inc. (ASMB), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading ASMB?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-01-04 | Christopher L. Jacobs | sell | $1K – $15K |
| 2020-12-28 | Christopher L. Jacobs | buy | $1K – $15K |